(Q66859778)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1068746%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

title

The current status of the treatment of childhood acute lymphoblastic leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1068746%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

main subject

lymphoblastic leukemia

1 reference

A. M. Mauer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1068746

19 August 2022

J. V. Simone

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1068746

19 August 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1068746

19 August 2022

publication date

1 March 1976

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1068746%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

published in

Cancer Treatment Reviews

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1068746%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1068746%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1068746%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

page(s)

17-41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1068746%20AND%20SRC:MED&resulttype=core&format=json

A comparative study of central nervous system irradiation and intensive chemotherapy early in remission of childhood acute lymphocytic leukemia

31 August 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Cessation of Therapy during Complete Remission of Childhood Acute Lymphocytic Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Response to combination therapy after relapse in childhood acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Treatment of central nervous system leukemia with intrathecal cytosine arabinoside

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Hypothalamic obesity in acute leukaemia. Report of a case

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Neurotoxicity and Elevated Cerebrospinal-Fluid Methotrexate Concentration in Meningeal Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Mental Retardation FollowingIn UteroExposure to the Atomic Bombs of Hiroshima and Nagasaki

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Induction of remission in acute leukemia with prednisone and intravenous methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Cytosine arabinoside and 6-thioguanine in refractory acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

L-asparaginase: clinical, biochemical, pharmacological, and immunological studies

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Studies of cellular proliferation in human leukemia. 3. Behavior of leukemic cells in three adults with acute leukemia given continuous infusions of 3H-thymidine for 8 or 10 days

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Irradiation, methotrexate toxicity, and the treatment of meningeal leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Short courses of cytosine arabinoside and L-asparaginase in children with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

CENTRAL NERVOUS SYSTEM INVOLVEMENT IN CHILDREN WITH ACUTE LEUKEMIA; A STUDY OF 921 PATIENTS

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

VINCRISTINE IN THE TREATMENT OF ACUTE LEUKEMIA IN CHILDREN

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

The increasing incidence of central nervous system leukemia in children. (Children's Cancer Study Group A).

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Acute leukemia—relapse after prolonged remission

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Chemotherapy of acute leukemia in childhood. Comparison of cyclophosphamide and mercaptopurine

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Thymic and splenic irradiation in treatment of acute lymphatic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Somnolence after Prophylactic Cranial Irradiation in Children with Acute Lymphoblastic Leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Proliferative Potential of Out-of-cycle Leukaemic Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

A study of “total therapy” of acute lymphocyticleukemia in children

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Intensive chemotherapy in children with acute lymphoblastic leukemia (L-2 protocol)

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Vincristine and prednisone for the induction of remissions in acute childhood leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

1 reference

7 January 2021

Chemotherapy of acute lymphocytic leukemia of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Clinical Study of Daunomycin and Prednisone for Induction of Remission in Children with Advanced Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Cytosine arabinoside. Results of a cooperative study in acute childhood leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

The role of vincristine in the treatment of childhood acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Encephalopathy in acute leukaemia associated with methotrexate therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

The need for chemotherapy after prolonged complete remission in acute leukemia of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Induction of remission in acute leukemia of childhood by combination of prednisone and either 6-mercaptopurine or methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Maintenance therapy in acute leukemia of childhood:Comparison of cyclic vs. sequential methods

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Treatment of acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

The use of combination therapy in leukemia remission

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Varying prednisone dosage in remission induction of previously untreated childhood leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Active immunotherapy for acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Extensive Histological and Cytological Survey of Patients with Acute Leukaemia in "Complete Remission"

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Daunorubicin: Results in Childhood Leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Additive therapy in the maintenance of remission in acute lymphoblastic leukemia of childhood: the effect of the initial leukocyte count

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Epidemiological factors and survival experience in 1770 children with acute leukemia. Treated by members of Children's Study Group A between 1957 and 1964

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Cyclophosphamide therapy in acute leukemia of childhood:Cooperative study conducted by members of children's cancer cooperative group A

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Five-year follow-up of "total therapy" of childhood lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Drug dosage and remission duration in childhood lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

The central nervous system in childhood leukemia: I. The arachnoid

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

CHROMOSOME STUDIES IN LEUKEMIA. I. EVIDENCE FOR THE ORIGIN OF LEUKEMIC STEM LINES FROM ANEUPLOID MUTANTS

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Subarachnoid distribution of drugs after lumbar injection

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Intrathecal aminopterin therapy of meningeal leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Disseminated necrotizing leukoencephalopathy: a complication of treated central nervous system leukemia and lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Sequential therapy of acute leukemia in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Variation of proliferative activity in leukemic cell populations of patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Reentry of nondividing leukemic cells into a proliferative phase in acute childhood leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Renal and hepatic pathology following initial remission of acute leukemia induced by prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Addition of local radiation after bone marrow remission in acute leukemia in children

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Combined modality therapy of acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Effects of central-nervous-system irradiation on neuropsychologic functioning of children with acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

L-asparaginase therapy in children with advanced leukemia. The Southwest Cancer Chemotherapy Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Bone-marrow transplantation (first of two parts).

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Cytosine arabinoside in acute leukemia of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Vincristine, prednisone, and daunomycin in acute leukemia of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

THE RESPONSE OF ACUTE CHILDHOOD LEUKEMIA TO AN INITIAL AND A SECOND COURSE OF PREDNISONE

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Intrathecal arabinosyl cytosine in meningeal leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

The neurologic manifestations of the acute leukemias: a clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

Predinsome therapy of acute childhood leukemia: Prognosis and duration of response in 330 treated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980015-1

7 January 2021

10.1016/S0305-7372(76)80015-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1068746%20AND%20SRC:MED&resulttype=core&format=json

31 August 2019

1 reference